AI-generated summary
The authors randomized 41 adults with mild-to-moderate facial acne to blue light therapy combined with proprietary creams (26 people) or a control group (15 people) and assessed inflammatory lesion counts over 12 weeks. They report a mean reduction of 50.02% in the treatment group and a 2.45% increase in the control group. The abstract describes this as a small randomized study whose results are reported as safe and effective as an add-on therapy.
- Participants
- 41
- Who or what was studied
- 41 adults with mild-to-moderate facial inflammatory acne
- Limits stated in the abstract
- The abstract reports a small sample, lesion counts assessed qualitatively from photography, and the treatment was combined with proprietary creams, so the blue light effect cannot be separated from the cream effect.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 414 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Light-emitting diode, Phototherapy, Anxiety. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.